VWF and hemophilia A: Since hemophilia A patients would not be deficient in vWF, the vWFnullFVIIInull strain can be used in a special situation to evaluate the factor VIII pharmacokinetics in the absence of vWF, which is especially valuable when engineered factor VIII may have altered interaction with vWF.